Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
Roth, Alexander, Barcellini, Wilma, D'Sa, Shirley, Miyakawa, Yoshitaka, Broome, Catherine M, Michel, Marc, Kuter, David J, Jilma, Bernd, Tvedt, Tor Henrik Anderson, Weitz, Ilene C, Patel, Parija, Jiang, Xiaoyu, Reuter, Caroline, Su, Jun, Shafer, Frank, Lee, Michelle, Berentsen, Sigbjorn
Published in Haematologica (Roma) (01.07.2022)
Published in Haematologica (Roma) (01.07.2022)
Get full text
Journal Article
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria
Brodsky, Robert A, Peffault de Latour, Régis, Rottinghaus, Scott T, Röth, Alexander, Risitano, Antonio M, Weitz, Ilene C, Hillmen, Peter, Maciejewski, Jaroslaw P, Szer, Jeff, Lee, Jong Wook, Kulasekararaj, Austin G, Volles, Lori, Damokosh, Andrew I, Ortiz, Stephan, Shafner, Lori, Liu, Peng, Hill, Anita, Schrezenmeier, Hubert
Published in Haematologica (Roma) (01.01.2021)
Published in Haematologica (Roma) (01.01.2021)
Get full text
Journal Article
Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment
Sutherland, Douglas E., Weitz, Ilene C., Liebman, Howard A.
Published in American journal of hematology (01.01.2003)
Published in American journal of hematology (01.01.2003)
Get full text
Journal Article
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D'Sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C., Yamaguchi, Masaki, Nishimura, Jun-ichi, Vos, Josephine M.I., Storek, Michael, Wong, Nancy, Patel, Parija, Jiang, Xiaoyu, Vagge, Deepthi S., Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M.
Published in Blood (01.09.2022)
Published in Blood (01.09.2022)
Get full text
Journal Article
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Kelly, Richard J, Höchsmann, Britta, Szer, Jeff, Kulasekararaj, Austin, de Guibert, Sophie, Röth, Alexander, Weitz, Ilene C, Armstrong, Elina, Risitano, Antonio M, Patriquin, Christopher J, Terriou, Louis, Muus, Petra, Hill, Anita, Turner, Michelle P, Schrezenmeier, Hubert, Peffault de Latour, Regis
Published in The New England journal of medicine (10.09.2015)
Published in The New England journal of medicine (10.09.2015)
Get full text
Journal Article
Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibition
Kulasekararaj, Austin G., Kuter, David J., Griffin, Morag, Weitz, Ilene C., Röth, Alexander
Published in Blood reviews (01.05.2023)
Published in Blood reviews (01.05.2023)
Get full text
Journal Article
Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
Röth, Alexander, Barcellini, Wilma, Tvedt, Tor Henrik Anderson, Miyakawa, Yoshitaka, Kuter, David J., Su, Jun, Jiang, Xiaoyu, Hobbs, William, Arias, Jaime Morales, Shafer, Frank, Weitz, Ilene C.
Published in Annals of hematology (01.10.2022)
Published in Annals of hematology (01.10.2022)
Get full text
Journal Article
Multidrug Therapy for Refractory Immune Thrombocytopenia in Pregnancy
Chon, Andrew H., Chan, Randall, Lee, Richard H., Kwong, Kenny, Wertheimer, Fiona B., Weitz, Ilene C.
Published in Obstetrics and gynecology (New York. 1953) (01.03.2020)
Published in Obstetrics and gynecology (New York. 1953) (01.03.2020)
Get full text
Journal Article
Life‐threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab
Boonyasampant, Mark, Weitz, Ilene C., Kay, Brian, Boonchalermvichian, Chaiyaporn, Liebman, Howard A., Shulman, Ira A.
Published in Transfusion (Philadelphia, Pa.) (01.10.2015)
Published in Transfusion (Philadelphia, Pa.) (01.10.2015)
Get full text
Journal Article
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease
Röth, Alexander, Barcellini, Wilma, D'Sa, Shirley, Miyakawa, Yoshitaka, Broome, Catherine M, Michel, Marc, Kuter, David J, Jilma, Bernd, Tvedt, Tor Henrik Anderson, Weitz, Ilene C, Yoo, Ronnie, Jayawardene, Deepthi, Vagge, Deepthi S, Kralova, Katarina, Shafer, Frank, Wardȩcki, Marek, Lee, Michelle, Berentsen, Sigbjørn
Published in American journal of hematology (01.08.2023)
Published in American journal of hematology (01.08.2023)
Get full text
Journal Article
Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
Röth, Alexander, Barcellini, Wilma, Anderson Tvedt, Tor Henrik, Miyakawa, Yoshitaka, Kuter, David J., Su, Jun, Jiang, Xiaoyu, Hobbs, William, Morales, Jaime, Shafer, Frank, Weitz, Ilene C.
Published in Annals of hematology (01.05.2024)
Published in Annals of hematology (01.05.2024)
Get full text
Journal Article
Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study
Röth, Alexander, Broome, Catherine M., Barcellini, Wilma, Jilma, Bernd, Hill, Quentin A., Cella, David, Tvedt, Tor Henrik Anderson, Yamaguchi, Masaki, Lee, Michelle, Shafer, Frank, Wardęcki, Marek, Jiang, Xiaoyu, Patel, Parija, Joly, Florence, Weitz, Ilene C.
Published in European journal of haematology (01.03.2023)
Published in European journal of haematology (01.03.2023)
Get full text
Journal Article
Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab
Tomazos, Ioannis, Sierra, J. Rafael, Johnston, Karissa M., Cheung, Antoinette, Brodsky, Robert A., Weitz, Ilene C.
Published in Hematology (Luxembourg) (01.01.2020)
Published in Hematology (Luxembourg) (01.01.2020)
Get full text
Journal Article
Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation
Weitz, Ilene C, Razavi, Pedram, Rochanda, Leanne, Zwicker, Jeffrey, Furie, Bruce, Manly, David, Mackman, Nigel, Green, Ralph, Liebman, Howard A
Published in Thrombosis research (01.09.2012)
Published in Thrombosis research (01.09.2012)
Get full text
Journal Article